Bench2Bedside AB is a Swedish consulting company specializing in Translational Medicine, helping biotech, pharmaceutical, life science, and academic organizations successfully bridge the gap between preclinical research and clinical development. Bench2Bedside AB is founded on more than two decades of experience in translational medicine, with a consistent focus on designing strategies that bridge preclinical research and clinical development. We work with partners internationally to develop robust translational strategies and biomarker plans that maximize the probability of clinical success and enable informed decision-making throughout the drug development process.